Todd holds a BSc in Bioengineering and Pre-Medicine from The Catholic University of America (Washington, USA). Todd is a highly successful international healthcare executive with more than 30+ years’ experience in life sciences companies. He has worked as global sales director for companies in molecular diagnostics, laboratory services, and medical devices such as Interleukin Genetics,…
Juan J. Diaz Mochón became CEO of DESTINA following the unexpected passing of Hugh Ilyine, founder and previous CEO of DESTINA. Juan worked with Hugh for more than 10 years as CSO of DESTINA. They worked in a true partnership with Juan managing all the scientific, research and technological activities of the company. He was…
David Whitcombe has more than 10 years of academic research and 15 years in industrial R&D. David has produced a number of publications and patents including the Scorpions technology that formed the basis of his start-up business DxS Ltd in 2000. He was Head of Technology Development at AstraZeneca Diagnostics for four years leading a…